PRMT5 and hepatocellular carcinoma: The S-adenosylmethionine (SAM)-binding domain (350–430 aa) of PRMT5 physically associates with LINC01138 in the HCC cells (Fig. 3f), and the LINC01138-binding abilities of the mutants without this domain were definitely dampened.